Serum MIR-21, MIR-29a, and MIR-125b are promising biomarkers for the early detection of colorectal neoplasia

Clinical Cancer Research

Volumn 21, Issue 18, 2015, Pages 4234-4242

  Yamada, Atsushi ^a,b   Horimatsu, Takahiro ^b   Okugawa, Yoshinaga ^a,c   Nishida, Naoshi ^d   Honjo, Hajime ^e   Ida, Hiroshi ^f   Kou, Tadayuki ^g   Kusaka, Toshihiro ^h   Sasaki, Yu ⁱ   Yagi, Makato ⁱ   Higurashi, Takuma ^j   Yukawa, Norio ^k   Amanuma, Yusuke ^b   Kikuchi, Osamu ^b   Muto, Manabu ^b   Ueno, Yoshiyuki ⁱ   Nakajima, Atsushi ^j   Chiba, Tsutomu ^b   Boland, C Richard ^a   Goel, Ajay ^a  

^a BAYLOR RESEARCH INSTITUTE   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c MIE UNIVERSITY   (Japan)

^d KINKI UNIVERSITY   (Japan)

^e OTSU RED CROSS HOSPITAL   (Japan)

^f Department of Orthopaedics   (Japan)

^g Kitano Hospital   (Japan)

^h KYOTO KATSURA HOSPITAL   (Japan)

ⁱ YAMAGATA UNIVERSITY   (Japan)

^j YOKOHAMA CITY UNIVERSITY   (Japan)

^k YOKOHAMA CITY UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 125B; MICRORNA 18A; MICRORNA 19A; MICRORNA 19B; MICRORNA 20A; MICRORNA 21; MICRORNA 24; MICRORNA 29A; MICRORNA 92; TUMOR MARKER; UNCLASSIFIED DRUG; MIRN125 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; MIRN29 MICRORNA, HUMAN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER SCREENING; COHORT ANALYSIS; COLORECTAL TUMOR; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICRORNA BLOOD LEVEL; PATIENT IDENTIFICATION; PRECANCER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; VALIDATION PROCESS; VERY ELDERLY; BLOOD; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; ENDOSCOPY; GENETICS; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; ENDOSCOPY; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE; YOUNG ADULT;

EID: 84942860025     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-2793     Document Type: Article

References (32)

1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014;64:104-17.
2. Howlader N NA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, et al. editors. SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute; 2014.
3. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009;104:739-50.
4. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95.
5. Qaseem A, Denberg TD, Hopkins RH Jr, Humphrey LL, Levine J, Sweet DE, et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med 2012;156:378-86.
6. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328: 1365-71.
7. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas A, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697-706.
8. Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, et al. Multitarget stool DNA testing for colorectal-cancer screening. NEngl J Med 2014;370:1287-97.
9. Schwarzenbach H, Nishida N, Calin GA, Pantel K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 2014;11: 145-56.
10. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNAexpression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103:2257-61.
11. Bartley AN, YaoH, Barkoh BA, Ivan C, Mishra BM, Rashid A, et al.complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer. Clin Cancer Res 2011;17:7283-93.
12. Shi X, Zhang Y, Cao B, Lu N, Feng L, Di X, et al. Genes involved in the transition from normal epithelium to intraepithelial neoplasia are associated with colorectal cancer patient survival. Biochem Biophys Res Commun 2013;435:282-8.
13. Wang S, Wang L, Bayaxi N, Li J, Verhaegh W, Janevski A, et al. AmicroRNA panel to discriminate carcinomas from high-grade intraepithelial neoplasms in colonoscopy biopsy tissue. Gut 2013;62:280-9.
14. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008;105:10513-8.
15. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006.
16. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009;58: 1375-81.
17. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010;127:118-26.
18. Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L, et al. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS One 2012;7:e44398.
19. Kanaan Z, Rai SN, Eichenberger MR, Roberts H, Keskey B, Pan J, et al. Plasma miR-21: a potential diagnostic marker of colorectal cancer. Ann Surg 2012;256:544-51.
20. Giraldez MD, Lozano JJ, Ramirez G, Hijona E, Bujanda L, Castells A, et al. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. Clin Gastroenterol Hepatol 2013;11:681-8 e3.
21. Hofsli E, Sjursen W, Prestvik WS, Johansen J, Rye M, Trano G, et al. Identification of serum microRNA profiles in colon cancer. Br J Cancer 2013;108:1712-9.
22. Luo X, Stock C, Burwinkel B, Brenner H. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. PLoS One 2013;8:e62880.
23. Toiyama Y, Takahashi M, Hur K, Nagasaka T, Tanaka K, Inoue Y, et al. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 2013;105:849-59.
24. Wang S, Xiang J, Li Z, Lu S,Hu J, Gao X, et al. A plasmamicroRNA panel for early detection of colorectal cancer. Int J Cancer 2015;136:152-61.
25. Faul F, Erdfelder E, Lang AG, Buchner A. G-Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-91.
26. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, Mongera S, Postma C, Meijerink WJ, et al. MiR-17-92 cluster is associated with 13q gain and cmyc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 2009;101:707-14.
27. Yamamichi N, Shimomura R, Inada K, Sakurai K, Haraguchi T, Ozaki Y, et al. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res 2009;15: 4009-16.
28. Akao Y, Nakagawa Y, Hirata I, Iio A, Itoh T, Kojima K, et al. Role of antioncomirs miR-143 and-145 in human colorectal tumors. Cancer Gene Ther 2010;17:398-408.
29. Fassan M, Pizzi M, Giacomelli L, Mescoli C, Ludwig K, Pucciarelli S, et al. PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch 2011;458:413-9.
30. Oberg AL, French AJ, Sarver AL, Subramanian S, Morlan BW, Riska SM, et al. miRNA expression in colon polyps provides evidence for amultihit model of colon cancer. PLoS One 2011;6:e20465.
31. Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012;107:1315-29; quiz 1314, 1330.
32. KirschnerMB, Edelman JJ, Kao SC, Vallely MP, van Zandwijk N, Reid G. The Impact of Hemolysis on Cell-Free microRNA Biomarkers. Front Genet 2013;4:94.